Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Mirtazapine for Fibromyalgia: An Effective Treatment Option?

Mirtazapine for Fibromyalgia: An Effective Treatment Option?

By

Mirtazapine is a central alpha-2 antagonist currently FDA-approved for the treatment of major depressive disorder.

Consensi Approved to Treat Hypertension and Osteoarthritis Pain

Consensi Approved to Treat Hypertension and Osteoarthritis Pain

By

Consensi combines amlodipine besylate, a calcium-channel blocker (CCB), and celecoxib, a nonsteroidal anti-inflammatory drug (NSAID).

First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms

First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms

By

Lucemyra, a selective alpha 2-adrenergic receptor agonist, works by reducing the release of norepinephrine and decreasing sympathetic tone.

Antidepressant Medications and Headache: Is There a Link?

Antidepressant Medications and Headache: Is There a Link?

By

Compared to placebo, selective serotonin reuptake inhibitors (SSRIs) were associated with a significantly higher risk of headache (risk ratio [RR] 1.06, 95% CI: 1.00 to 1.13; P =.045).

Walmart Plans on Restricting Supply on Acute Opioid Prescription Fills

Walmart Plans on Restricting Supply on Acute Opioid Prescription Fills

By

For states that currently limit new acute opioid prescription fills to <7 days, Walmart and Sam's Club pharmacies will follow that state law.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-Newsletters